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Identification of genes expressed in 
a mesenchymal subset regulating 
prostate organogenesis using tissue 
and single cell transcriptomics
Nadia Boufaied1, Claire Nash1, Annie Rochette1, Anthony Smith1, Brigid Orr2, O. Cathal 
Grace2, Yu Chang Wang3, Dunarel Badescu3, Jiannis Ragoussis3 & Axel A. Thomson1
Prostate organogenesis involves epithelial growth controlled by inductive signalling from specialised 
mesenchymal subsets. To identify pathways active in mesenchyme we used tissue and single cell 
transcriptomics to define mesenchymal subsets and subset-specific transcript expression. We 
documented transcript expression using Tag-seq and RNA-seq in female rat Ventral Mesenchymal 
Pad (VMP) as well as adjacent urethra comprised of smooth muscle and peri-urethral mesenchyme. 
Transcripts enriched in female VMP were identified with Tag-seq of microdissected tissue, RNA-seq 
of cell populations, and single cells. We identified 400 transcripts as enriched in the VMP using bio-
informatic comparisons of Tag-seq and RNA-seq data, and 44 were confirmed by single cell RNA-seq. 
Cell subset analysis showed that VMP and adjacent mesenchyme were composed of distinct cell types 
and that each tissue contained two subgroups. Markers for these subgroups were highly subset specific. 
Thirteen transcripts were validated by qPCR to confirm cell specific expression in microdissected 
tissues, as well as expression in neonatal prostate. Immunohistochemical staining demonstrated that 
Ebf3 and Meis2 showed a restricted expression pattern in female VMP and prostate mesenchyme. 
We conclude that prostate inductive mesenchyme shows limited cellular heterogeneity and that 
transcriptomic analysis identified new mesenchymal subset transcripts associated with prostate 
organogenesis.
The development of the prostate is regulated by androgens and mesenchymal:epithelial interactions. Several stud-
ies have demonstrated that paracrine acting factors made in the mesenchyme play key roles in regulating male 
reproductive organogenesis. Pathways such as Fgf, Wnt, TGFbeta, Shh, Notch, and others have been identified 
as participating in prostate development, though it is uncertain whether our knowledge of regulatory pathways 
is comprehensive (reviewed in1). Transcriptional profiling has been applied to whole prostate organs, both in 
development and adulthood2–6. These studies have identified dynamic expression of many pathways. However, 
the cellular complexity and proportions of different cell types within organs has led to difficulty in attribution of 
individual transcripts to defined cell subsets, as well as being confounded by changes in cell proportions over time 
or following hormonal manipulation. Within these datasets, it is difficult to deconvolute pathways expressed in 
either stromal or epithelial tissue compartments, although some studies have focussed upon mesenchymal and 
stromal tissue7,8. Since mesenchyme is known to regulate organogenesis as well as mediate the effects of hormones 
upon development, it is important to identify mesenchymally expressed pathways.
During prostate development, several morphogens are expressed in a subset of mesenchyme termed the 
Ventral Mesenchymal Pad (VMP) and the peri-urethral mesenchyme. The VMP is most apparent on the ventral 
aspect of the urethra but it encircles the urethra. Its formation precedes the formation of the ventral, lateral and 
dorsal prostate lobes. It has been defined as a source of inductive mesenchyme using tissue recombination studies9, 
1Department of Surgery, Division of Urology, Cancer Research Program, McGill University Health Centre, 1001 
Decarie Boulevard, Montreal, Quebec, H4A 3J1, Canada. 2MRC Human Reproductive Sciences Unit, The Queen’s 
Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK. 3McGill University and Genome 
Quebec Innovation Centre, 740 Dr. Penfield Avenue, Montreal, H3A 0G1, Canada. Nadia Boufaied and Claire Nash 
contributed equally to this work. Correspondence and requests for materials should be addressed to A.A.T. (email: 
axel.thomson@mcgill.ca)
Received: 5 September 2017
Accepted: 16 November 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCienTifiC REPORts | 7: 16385  | DOI:10.1038/s41598-017-16685-8
and several pathways show VMP-specific expression8,10. Other regions of the stroma also show subset-specific 
marker and pathway expression, such as smooth muscle and peri-urethral stroma. A detailed anatomic descrip-
tion of stromal subsets has been described, and defined using specific markers11–13. The VMP forms in both males 
and females9,14 and constitutively expresses morphogens such as Fgf1010. This has led to the question of whether 
androgens regulate morphogen expression, which has conflicting experimental support (reviewed in1,15,16). It has 
been shown that androgens control the formation of a sexually dimorphic layer of smooth muscle that separates 
VMP mesenchyme from nascent prostatic buds17,18. This layer may regulate inductive signalling from the VMP, 
and constitutes part of the hormonal mechanism controlling prostate organogenesis. The smooth muscle hypoth-
esis accounts for the non-dimorphic expression of Fgf10 and other morphogens16. A prediction of this hypothesis 
is that morphogens are constitutively expressed in both males and females but are regulated indirectly by andro-
gens and AR acting in the smooth muscle compartment. We have used VMP isolated from females on the day of 
birth as our model of prostate mesenchyme, since this is when the tissue is largest and also because female VMP 
lacks prostatic epithelia and is of low cellular complexity. At the same age in males, the VMP has become the 
Ventral Prostate, and contains a high proportion of branching epithelia, while the mesenchyme is differentiating 
into smooth muscle and other fibroblast types. Thus, female VMP is a model system with low cellular complexity 
that is optimal for identification of molecules involved in prostate development. We have previously used SAGE 
to identify transcripts specifically expressed in the VMP8, and noted that mesenchymal pathways may be dys-
regulated in cancer-associated fibroblasts, associated with EMT, or neuro-endocrine differentiation of tumours. 
These studies identified Ptn, Dlk1/Notch2, Scube1, EfnB1/EphB3, and Dcn in prostate development8,19–22. One of 
the limitations of SAGE is its low sensitivity in transcript detection, and next generation RNA sequencing based 
methods such as Tag-sequencing (Tag-seq) and RNA-sequencing (RNA-seq) have considerably higher sensitivity 
and superior transcript quantitation, as well as high resolution techniques such as single cell RNAseq.
The rationale for our study was to conduct a high resolution transcriptomic analysis of mesenchymal sub-
sets and to examine homo/heterogeneity in regard to cellular composition, as well as to catalogue transcript 
expression. Cellular heterogeneity is a significant problem in whole organ and tissue transcriptional profil-
ing. Comparison of transcript profiling from microdissected tissue and single cell RNA-seq (scRNA-seq) was 
used to identify transcripts with tissue and cell specific expression. The markers and pathways identified by 
such an approach can be deconvolved in whole organ datasets and prioritised for functional studies. We val-
idated expression of VMP-specific transcripts by qPCR and also confirmed expression in neonatal prostate. 
Immunohistochemistry of Ebf3 and Meis2 confirmed expression in VMP and prostate mesenchyme.
Results
Tag-seq and RNA-seq of microdissected mesenchymal tissues. VMP mesenchyme was microdis-
sected from day of birth (P0) female rat urethra to isolate pure VMP mesenchyme as well as adjacent urethra 
comprised of smooth muscle, peri-urethral stroma and urethral epithelia (SU). Tissue pools were collected and 
processed for Tag-seq. As a comparator, pools of microdissected tissues were dissociated using collagenase, and 
1000 cells from each pool used for RNA-seq. This dissociation enriched for mesenchymal cells in the SU sample, 
since epithelia remained intact and were separated from the stromal cells. VMP is wholly mesenchymal, though 
may contain residual traces of epithelia following dissection. Figure 1a shows a schematic diagram of female 
urethra, while Fig. 1b shows images of tissue dissection and subsequent analysis. Figure 1c shows Tag-seq and 
RNA-seq library details, as well as identification of differentially expressed transcripts using NOISeq a method 
based on empirical distribution suitable for comparison of 2 samples with no replicates23. Tag-seq identified 1169 
VMP and 1364 SU differentially expressed (DE) transcripts, while RNA-seq identified 761 VMP and 975 SU 
DE transcripts (Fig. 1c). When transcripts identified as differentially expressed were compared between the two 
different techniques (Tag-seq and RNA-seq) we observed 400 transcripts as common to both (Fig. 1d). The fold 
difference of DE transcripts showed similar distributions between Tag-seq and RNA-seq in VMP and SU subsets 
(Supplementary Figure 1). Comparison of the DE transcripts to the human foetal prostate transcriptome19,24 
(EMB) co-identified 219 transcripts suggesting that a high proportion (54%) of DE transcripts are expressed 
during human prostate development (Supplementary Figure 2). At early stages of human prostate development, 
the organ contains a high proportion of mesenchyme, which likely contributes to the similarity between VMP 
and foetal prostate transcriptomes.
Gene Set Enrichment Analysis of subset-specific transcripts. Visualisation of the 400 differentially 
expressed transcripts by heatmap supported the differential expression between VMP and SU, which was also 
evident in transcripts previously identified as VMP specific or enriched (Scube1, Nell2, Rspo2, Rspo3, Ptn, Igf2, 
Sfrp1, Fgf10)8 (Fig. 2a). Gene Ontology analysis identified regulation of epithelial cell proliferation, migration and 
growth factor response as associated with VMP enriched transcripts (Fig. 2b), as well processes involved in gly-
cosaminoglycan binding and axon guidance. Molecular functions such as Wnt and Vegf protein binding as well as 
promoter DNA binding were also identified as significant in VMP enriched transcripts (Supplementary Figure 3). 
Gene Ontology analysis of SU identified several pathways associated with muscle development consistent with its 
tissue composition (Fig. 2b).
Single cell RNAseq of mesenchymal subsets. To examine transcript expression and identify DE 
transcripts at single cell resolution, we performed scRNA-seq on dissociated cells derived from microdissected 
VMP and SU. VMP and SU single cells were isolated using a Fluidigm C1 chip, RNA-seq libraries were prepared 
and sequenced. scRNA-seq data was quality controlled to remove cells with low library size and low number of 
mapped genes as well as a high ratio of reads mapped to mitochondrial DNA and spike-in controls. The distribu-
tion of library size, number of mapped genes, proportion of reads mapped to mitochondrial DNA and proportion 
of reads mapped to spike-in controls are shown in Supplementary Figure 4a,b. Cell cycle was analysed in all cells 
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and represented a median of 3.16% of gene expression variance (Supplementary Figure 5). We performed a PCA 
plot (Supplementary Figure 5c,d) and observed a clear separation of cells according to cell type (PC2 R2 = 0.58) 
but not according to cell-cycle stage (PC23 R2 = 0.17) indicating that cell cycle has a minor confounding effect. 
We have observed that VMP cells do not grow as primary cultures, but that SU stroma will grow in vitro (unpub-
lished), and we suggest that differences between VMP and SU tissues may include factors related to proliferation, 
but that differences in cell cycle are a minor component of our data. In total 49 VMP and 62 SU single cells passed 
quality control and were used for further analysis. The landscape of cells in 2D space is shown by principal com-
ponent analysis (PCA) and showed a separation between VMP and SU cell types demonstrating that dissociated 
cell populations retained their different tissue identities (Fig. 3a). Two algorithms (MAST25 and scDD26) were 
Figure 1. Identification of transcripts differentially expressed in VMP and SU tissues using Tag-seq and RNA-
seq. (a) A schematic diagram of P0 female urethra illustrating the position of the VMP on the urethra, and an 
adjacent region of urethra comprised of smooth muscle and urethral epithelia (SU). Vg = Vagina, Cx = Cervix, 
Ut = Uterus; only one uterine horn is illustrated. (b) P0 urethra was micro-dissected to yield VMP mesenchyme 
and adjacent SU. Micro-dissected VMP consists of pure mesenchyme and lacks epithelia, while SU contains 
both mesenchyme and epithelia. Tag-seq libraries were prepared from microdissected VMP and SU tissues 
(Tissue), while RNAseq libraries were prepared from cell suspensions from tissue digested with collagenase 
(Cells). This enabled the removal of urethral epithelium from the SU cell sample. (c) Details of Tag-seq and 
RNA-seq libraries, and differentially expressed transcripts. A statistical package, NOISeq, was used to define 
differentially expressed (DE) transcripts in both Tag-seq and RNA-seq datasets. Transcripts with an absolute 
log2 fold-change (M) ≥ 1.5 and a diverge probability (q) > 0.9 were considered to be differentially expressed. (d) 
Venn diagram showing overlap between DE transcripts in Tag-seq vs RNA-seq data, and identification of 400 
DE transcripts common to both techniques.
www.nature.com/scientificreports/
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Figure 2. Differential expression of transcripts between VMP and SU, and Gene Ontology of pathways 
associated with tissue subsets. (a) Heatmap representing expression values of the 400 differentially expressed 
transcripts (M ≥ 1.5 and q > 0.9) between VMP and SU identified by both Tag-seq and RNA-seq, as well as 
previously published markers of VMP (Nell2, Sfrp1, Igf2, Fgf10, Ptn, Dlk1). The colour key represents log2-
trimmed mean of M component normalized read counts (log2(RC)). Both Tag-seq and RNA-seq identified 
transcripts showing differential expression between SU and VMP (b) Gene ontology analysis of VMP and SU 
enriched transcripts. The figure shows the biological process group found with an FDR adjusted P-value < 0.05. 
Bar length represent the number of VMP and SU enriched transcripts in each group and the shade of colour the 
adjusted P-value for the enrichment. VMP showed enrichment of pathways related to regulation of epithelial 
proliferation, migration and response to growth factors, while the SU showed enrichment of pathways related to 
muscle development consistent with its tissue composition.
www.nature.com/scientificreports/
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Figure 3. Single-cell RNA-seq of dissociated VMP and SU cells. Microdissected tissues were digested with 
collagenase to provide single cell suspensions for separation using a Fluidigm C1 microfluidic chip, and 
subsequent library preparation and sequencing. (a) PCA plot of whole transcriptome data distinguished 
VMP from SU cells. (b) Venn diagram showing the overlap between the DE transcripts identified by MAST 
(Benjamini-Hochberg adjusted P-value < 0.05) and the DE transcripts identified by scDD method (fold 
change > 1.5 and Benjamini-Hochberg adjusted P-value < 0.05). (c) Heatmap representing the log2 expression 
values (normalized read count + 1) (RC) of the common 352 DE transcripts between VMP and SU cells. (d) 
Venn diagram of DE transcripts identified by Tag-seq/RNA-seq and DE transcripts identified in scRNA-seq. 
44 transcripts were common between both approaches. (e) Violin plots showing the distribution of log2 
(normalized read count + 1) (RC) across VMP (top row) and SU (bottom row) cells for selected DE transcripts 
with adjusted P-value < 0.0001 identified by MAST and scDD.
www.nature.com/scientificreports/
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used to identify DE transcripts from scRNA-seq data. 513 and 1407 DE transcripts were identified by MAST 
and scDD respectively with 352 transcripts common to both (Fig. 3b). Visualization of the 352 DE transcripts by 
heatmap and hierarchical clustering showed a clear separation between VMP and SU cell populations (Fig. 3c). 
Figure 3d shows a Venn diagram of DE transcripts from tissue based analysis (400) compared to DE transcripts 
in scRNA-seq (352), which identified 44 transcripts as common to both. To further assess the effect of cell cycle 
status on DE transcript analysis, we compared the 352 DE transcripts to the list of cell cycle associated genes. 
A minority of DE transcripts (19, ~5%) were found to be cell cycle associated (Supplementary Figure 6a). We 
also identified DE transcripts between VMP and SU cells using MAST with or without adjusting for cell cycle. 
We found that correcting for cell cycle bias made a minor difference to the results (513 vs 578 transcripts; 453 
common between analyses) (Supplementary Figure 6b). Comparison of the DE transcripts to the human foetal 
prostate transcriptome19,24 co-identified 27 transcripts suggesting that a high proportion (61%) of scRNA-seq 
identified DE transcripts are also expressed during human prostate development (Supplementary Figure 7). The 
distribution of expression of the transcripts was visualized by violin plot and demonstrated cell population spec-
ificity between VMP and SU cells (Fig. 3e and Supplementary Figure 8). Gene ontology analysis was performed 
on DE transcripts and significantly enriched terms were identified in the SU compartment only (Supplementary 
Figure 9). Pathways such as urogenital system development and functions such as Wnt pathway protein binding 
were identified supporting the gene ontology analysis performed on Tag- and RNA-seq whole tissue samples. We 
compared our data with an earlier SAGE analysis of VMP transcript expression, this identified a low percentage 
overlap (4%) but among the co-identified were Dlk1 and Ptn which were experimentally confirmed as VMP spe-
cific20,27 (Supplementary Figure 10).
Analysis of cellular heterogeneity using single cell RNAseq. We next performed a subset analysis 
using two algorithms (Seurat28 and SC329) to determine whether VMP and SU cells were homogeneous or com-
posed of subgroups. With both algorithms, single cells were organized into four distinct clusters (two VMP and 
two SU clusters, Fig. 4 & Supplementary Figure 11). tSNE analysis showed organization of cells into 4 distinct 
clusters in 2D space (Fig. 4a). This suggests that VMP and SU compartments are not homogeneous. Transcripts 
enriched within each of the four clusters were identified using the Seurat algorithm by first identifying the most 
variable genes between each cluster followed by a statistical ROC analysis to identify the transcripts differen-
tially expressed between each of the four clusters. A total of 846 DE transcripts were identified between the four 
clusters with an AUC score > 0.75 and a power score > 0.4. Of these, 290 were classified as enriched for cluster 
1 (SU cells), 294 were classified as enriched for cluster 2 (SU cells), 103 were enriched for cluster 3 (VMP cells) 
and 159 were enriched for cluster 4 (VMP cells). The expression of these transcripts were visualized by heatmap 
and showed a clear separation of the four cell clusters (Fig. 4b). Figure 4c and Supplementary Figure 12 shows 
the distribution of expression of representative transcripts from each of the four clusters by violin plot at single 
cell resolution.
Validation of compartment specific transcript expression by qPCR. To validate differential expres-
sion of VMP and SU enriched transcripts, we performed qPCR upon pooled microdissected tissues. In addition 
to VMP and SU tissues, we included ventral prostate (VP) and dorsal/dorsolateral prostate (DP) to compare 
expression between VMP and prostate lobes. Prostate tissue was composed of both mesenchyme and epithe-
lia, thus mesenchyme-specific transcripts would be diluted due to the presence of epithelia in VP and DP. We 
examined 11 of our differentially expressed transcripts by qPCR in VMP, SU, VP and DP samples (Fig. 5), as 
well as a panel of known VMP enriched (Fgf10, Ptn, Scube1) or SU enriched (Aldh1a3, Wnt5a, Lef1 and Bmp4, 
Supplementary Figure 13) transcripts. Overall, our VMP differentially expressed transcripts were significantly 
enriched in VMP tissues versus SU tissues by qPCR. This validated our bioinformatic approaches for identifica-
tion of VMP enriched transcripts. A subset of transcripts also showed VMP enrichment as well as expression in 
VP and DP. Our SU enriched transcripts outperformed known SU enriched markers upon validation by qPCR 
(Fig. 5 and Supplementary Figure 13).
Immunohistochemical localisation of subset specific proteins Ebf3 and Meis2. In order to deter-
mine whether the differentially expressed transcripts were cell subset specific, we examined protein expression by 
immunohistochemistry upon P0 female and male urethra focussing upon the prostate and VMP. We chose two 
VMP enriched markers, transcription factors Ebf3 and Meis2, and documented their expression in serial sections 
of female and male P0 rat urogenital sinus tissue (Fig. 6). We observed that Ebf3 was nuclear and largely homoge-
neously expressed in female VMP cells. Protein expression was markedly reduced in the SU versus the VMP cell 
compartments supporting our transcriptomic data. In male tissues, Ebf3 was nuclear and restricted to the mesen-
chymal cells of the developing ventral prostate with no expression in the epithelial cells of ventral prostatic buds. 
Meis2 showed a similar nuclear and mesenchymal cell specific expression pattern in both female and male tissues.
Discussion
The ventral mesenchymal pad (VMP) is a subset of urogenital mesenchyme which has been shown to express 
potent morphogens and regulate prostate organogenesis9,30. Signalling from the VMP and urogenital sinus mes-
enchyme can re-specify epithelial fate31 and partially re-differentiate prostate tumour epithelium32. Recently, we 
identified Asporin (ASPN) as expressed within a subset of human prostate mesenchyme20, and showed that ASPN 
was a marker of prostate tumour stroma associated with disease progression33. Similarly, expression of VMP 
specific morphogens in cancer associated fibroblasts was able to reduce tumour growth in a human prostate 
tumour reconstitution model34. This demonstrates the significance of the VMP as a source of stromal-specific 
molecules with potent capacity to regulate epithelial growth and differentiation in both development and disease. 
We suggest that mesenchymal subsets are enriched for regulators and morphogens, as well as factors associated 
www.nature.com/scientificreports/
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with paracrine signalling between mesenchyme and epithelium or juxtacrine signalling between mesenchymal 
subsets. Our studies are among the first to catalogue gene expression in inductive mesenchyme, and address cel-
lular heterogeneity within the mesenchymal compartment.
In this study, our goal was to identify molecules specific to the VMP and to examine cell and tissue hetero-
geneity within the mesenchyme. We performed both Tag-seq and RNA-seq on VMP as well as an adjacent mes-
enchyme comprised of urethral epithelium and peri-urethral mesenchyme (termed SU). Comparison of VMP 
Tag/RNA-seq libraries to SU libraries identified 400 transcripts that were differentially expressed between the 
two compartments. Among these were several transcripts identified as VMP-specific in a previous SAGE study8, 
Figure 4. Identification and characterization of distinct cell subpopulations within VMP and SU tissue 
compartments. (a) tSNE analysis identified markers of cell subpopulations that separates both VMP and SU 
in to two distinct VMP and two distinct SU cell subpopulations labeled clusters 1 through 4 respectively. (b) 
Expression heatmap of most discriminatory cluster markers (avg_diff > 0 and AUC > 0.75) across VMP and SU 
cell populations. Expression values presented as log2 (TPM + 1) (TPM). (c) Violin plots showing expression of 
selected cluster marker genes across VMP and SU cell populations. Expression is presented as log2 (TPM + 1). 
Width of the violin plot indicates frequency of cells with that expression level.
www.nature.com/scientificreports/
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which served as controls for our analysis (Fig. 2). The identification of particular transcripts with different tech-
niques supports the reproducibility of our results. Gene set enrichment analysis of VMP enriched transcripts were 
associated with biological signalling pathways related to epithelial cell migration, differentiation and proliferation 
consistent with the function of the VMP as a potent regulator of epithelial cell development. The VMP is part 
of a condensed area of mesenchyme that encircles the urethra and which overlies peri-urethral mesenchyme. It 
appears that there was significant expression of regulatory pathways in both the VMP and peri-urethral mesen-
chyme. A recent ontology analysis has described the distribution of mesenchymal subregions35 and our results 
provide molecular characterisation of these subsets. While there is paracrine signalling between mesenchyme and 
Figure 5. Validation of VMP- and SU-specific transcript expression in female and male P0 rat tissues. 
Quantitative real-time PCR (qPCR) showed significantly elevated levels of both control (Fgf10, Ptn and Scube1) 
and candidate (Ebf3, Gfra3, Nmur2, Rspo2, Scara5, Slc26a7, Robo1 and Meis2) VMP-specific transcripts versus 
SU. Fgf10, Ptn, Scube1, Ebf3, Gfra3, Scara5 and Meis2 were expressed in VP and DP, while Rspo2, Nmur2 and 
Slc26a7 showed low expression in VP and DP. SU candidate transcripts Anxa1, Enpp2 and Unc5b were enriched 
versus VMP. Data is represented as mean fold difference to VMP ± SD of duplicate biological replicates and 
duplicate technical replicates (n = 4). Significance was detected using One-way ANOVA with TUKEY multiple 
comparison *p < 0.05. Figures in red indicate fold difference compared to VMP.
www.nature.com/scientificreports/
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epithelium, we speculate that there is also juxtacrine signalling between different mesenchymal compartments. 
It may be possible to bioinformatically identify ligands and receptors with reciprocal expression between mesen-
chymal subsets. Differences between VMP and SU were confirmed using scRNA-seq analysis, which showed dis-
tinct gene expression between these compartments and co-identified 44 transcripts observed in the tissue-based 
analysis. Deeper analysis of the scRNA-seq data determined that both VMP and SU were comprised of 2 subsets 
(Fig. 4). This analysis also identified subset specific markers, and suggested that there was low heterogeneity 
within the VMP and SU compartments. At present, we do not know the functional significance of the two sub-
groups that make up the VMP and SU compartments, however, this heterogeneity will be important to consider 
when using tissue-specific promoters for gene targeting as many promoters will be active in a proportion of cells 
rather than throughout all cells in the tissue.
Several of the markers identified in VMP and SU were validated by qPCR and simultaneously examined 
for their expression in male developing prostate. We propose that VMP mesenchyme provides a simpler model 
Figure 6. Immunohistochemistry of Ebf3 and Meis2 in female VMP and male prostate. To examine the 
distribution of Ebf3 and Meis2 in mesenchymal subsets in VMP and ventral prostate (VP) we performed 
immunohistochemistry using P0 rat female and male reproductive tracts. Panels (a–d) show Ebf3 expression; 
in female (a and c) and male (b and d). Ebf3 showed a highly selective distribution within VMP and VP 
mesenchyme, and was absent from smooth muscle (SM) and the urethra (c, a and b). Panels (e–h) show Meis2 
distribution; in female (e and g) and male (f and h) mesenchyme. Urethral epithelia (URE) and prostatic 
epithelia (E) were negative for both Ebf3 and Meis2. Scale bars (a,b,e and f) = 600 µm. Scale bars (c,d,g and 
h) = 300 µm.
www.nature.com/scientificreports/
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for the identification of mesenchyme specific molecules since it lacks branching epithelia. Inclusion of these 
in whole tissue transcriptomics yields more complex data in which it is difficult to deconvolve mesenchyme 
specific molecules. Comparison between male and female mesenchyme may be used to identify sexually dimor-
phic gene expression and regulation by androgens and the androgen receptor, and we chose to focus upon 
mesenchyme-specific expression rather than sexually dimorphic expression. We note that some of our mark-
ers exhibit differences between male and female mesenchyme which could be validated in future studies. This 
is important, since androgen action within the mesenchymal compartment regulates both prostate and genital 
tubercle growth, and we propose that identification of mesenchyme specific molecules is a first step in the discov-
ery of such factors.
We identified Meis homeobox 2 (Meis2) and early B-cell factor 3 (Ebf3) as specific to the VMP compared 
to SU, and also expressed in prostatic mesenchyme. Meis2 belongs to the TALE homeobox protein family and 
is a regulator of transcription36. Meis2 has been identified as essential for the development of cardiac, orofacial, 
gastro-esophageal and neural tissues37–39. Ebf3 is a DNA-binding transcription factor which is involved in the 
development of bone and neural tissues40,41. Here we have established specific expression and nuclear localisation 
of Meis2 and Ebf3 in developing prostate mesenchyme and are the first to associate these transcription factors 
with prostate development and expression within mesenchymal subsets. We propose that these molecules can 
be used as specific markers of mesenchyme or stroma and could be used to estimate the abundance of stroma vs 
epithelium in tissues of mixed cellular composition.
In conclusion, we present a high-resolution transcriptomic analysis of inductive prostate mesenchyme that 
has documented limited cellular heterogeneity within subsets and identified markers and pathways expressed in 
mesenchyme during early prostate organogenesis.
Methods
Animal and tissue collection. Wistar rats were housed under a 12-hour light/dark cycle and maintained on 
standard laboratory diet, the study was performed under MUHC animal protocol number 2015–7670, approved 
by the McGill University Facility Animal Care Committee (FACC). Newborn (P0) pups were sacrificed by cervi-
cal dislocation and decapitation (in accordance with local guidelines and regulations), followed by removal of the 
urogenital tract and microdissection of the urethra into VMP and SU components using a Leica MZ6 dissection 
microscope.
Tag-sequencing library preparation. Pools of microdissected tissues (VMP and SU) from over 100 ani-
mals were processed for digital gene expression Tag-profiling using NlaIII and a protocol provided by Illumina 
followed by sequencing on an llumina GAIIX (1 × 50 SE) at one lane per sample (25–30 m reads). PolyA + RNA 
was purified, cDNA synthesised, digested with NlaIII and ligated to Adaptor 1 (containing an Mme1 site). 
Samples were digested with Mme1, ligated to Adaptor 2, and PCR amplified, followed by gel electrophoresis and 
purification of 85 bp fragments that were sequenced. DNA sequencing was carried out in the GenePool genomics 
facility in the University of Edinburgh.
Gene Forward primer (5′–3′) Reverse primer (3′–5′)
Fgf10 GGGAAACTCTATGGCTCAAAAG TGCCACATACATTTGCCTGC
Ptn GCCTCAAGCGGAATCAAAGA ATCCTGCTTGCTGATGTCCT
Scube1 CCTATGACGAGGACTACCAG TCTCCTGATGGTTCTCCGA
Ebf3 GCAACACTCCAGCACACACT ATTGCGACTGTAGCCGACTT
Gfra3 CACCCTATGGACATCCTCG CATGGCAGTCCCAATTAGC
Nmur2 CCTTGAGGCGAACAAAGTG AGGACCAAGACAAACAGCA
Rspo2 GGAGAGTGTCTGCATTCCT TATTCTGCATCTTGCACATCTG
Scara5 CAACGGCTCCATCTTTGAG TTGTGACATGGACCATCCT
Slc26a7 TTGGTCCTGAATTGCAGTG CTTGCAATCAAGGTAGAGCTC
Robo1 AGGTTTGGTGTCTCGGGAAT AGCGGATTCCAGGAACAAGA
Meis2 TGACCTCGTGATTGATGAGAG AGGATGAAGGGTTGTGGTC
Anxa1 AAAGGTGTGGATGAGGCAAC TATGCTGCCTTGATCTGCTG
Enpp2 CATTCCAGGTAATATCCTTGTTCAC CCCTCTTAATTCGACTTGCTG
Unc5b AGGTACCCTTGGATCATGAG TCTTGAGCCATTCCACCTC
Aldh1a3 CTACAACGCATTCTATGCAC AAAGCGTATTCACCTAGTTCTC
Wnt5a CAAGGGCTCCTATGAGAGC GCCAGGTTGTATACTGTCCT
Lef1 TAGCAGACATCAAGTCATCCT GTGTTTGTCTGACCACCTC
Bmp4 ATCACGAAGAACATCTGGAG CTCATTCTCTGGGATGCTG
Gapdh ATGACTCTACCCACGGCAAG GATCTCGCTCCTGGAAGATG
Tbp GCTGAATATAATCCCAAGCGGT TGTGCACACCATTTTCCCAG
Gusb TGGTATAAGATGTACCAGAAGCC AGGTGGATCCTCATGAAGC
Mt-atp6 TGAGCCCTAATAATTGTATCCC GAAGCCCTAGAAGGTTGGT
Table 1. Summary of primers used for qPCR.
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Single-cell RNA-sequencing library preparation. Dissociated cells derived from collagenase diges-
tion of pools of microdissected VMP and SU using collagenase 1 A at 2 mg/mL concentration (Sigma-Aldrich, 
Missouri, USA) for 60 minutes at 37 °C. Dispersed fibroblasts were separated from epithelia and tissue clumps by 
centrifugation through a 0.7μm cell strainer (Falcon® Corning, Corning, New York, USA).
Cell suspensions were centrifuged for 10 minutes at 500 g and resuspended in LIVE/DEAD Cell Viability/
Cytotoxicity Assay for mammalian cells (ThermoFisher, L-3224). After a 10-minute incubation at room tempera-
ture, cells were centrifuged and resuspended in Cell Wash Buffer (Fluidigm). Cell concentration, size and viability 
were verified on hemocytometers (Incyto DHC-N01–5) through bright field, GFP and RFP on a EVOS FL Auto 
microscope (ThermoFisher). Single cell RNA libraries were constructed according to the Fluidigm protocol using 
C1 to generate libraries for RNA sequencing (PN 100–7168). Briefly, full length mRNA-seq libraries were gener-
ated from single-cells captured on the Fluidigm C1 platform using SMARTer Ultra Low RNA Kit (P/N 634936 
Clontech). ERCC RNA Spike-In mix (P/N 4456740 ThermoFisher) was added to the lysis mix for normalization 
and quality control purposes. Full length cDNAs were converted into sequence ready libraries using Nextera XT 
DNA Sample Preparation Kit (P/N FC-131–1096 Illumina), and sequenced on an Illumina HiSeq2000/2500 with 
paired-end 100/125 option. In parallel, for every sample, sequencing libraries from bulk cells (200 cells) using 5 
ng of purified total RNA, and a negative control were run on a thermocycler (T100 BioRad).
The Fluidigm C1 platform captured 52 and 70 single cells from VMP and SU respectively. The average full length 
cDNA yield/min/max were 6.06ng(+/−0.12)/2.25ng/14.81ng for VMP and 8.51ng(+/−0.21)/2.55ng/26.6ng for 
SU. Libraries from 52 VMP and 63 SU single cells were sequenced.
Cells from the cell suspensions were processed to provide a ‘bulk’ comparator for single cell studies.
Tag-sequencing read alignment. Raw sequencing reads were trimmed to 17 bp to remove adaptor 
sequences and restriction digestion sites. Reads were quality controlled using FastQC42 to keep only reads with a 
mean quality score of 20 and above. Reads were aligned to the rat genome (Ensembl Rnor_6.0) using the Bowtie2 
algorithm (default settings)43. Reads aligned to random contigs and mitochondrial DNA were removed and only 
uniquely mapped reads with a mapping quality >=25 were used for further analysis.
Single-cell RNA-sequencing read alignment. Raw paired-end reads were trimmed using Trimmomatic 
v0.3344, to a minimum length of 30 nucleotides. Illumina Nextera XT adapters were removed in palindrome 
mode. A minimum Phred quality score of 30 was required for the 3′ end. Single end reads as well as paired end 
reads failing previous minimum quality controls were discarded. Individual read groups were aligned, using 
TopHat45 first against the rat transcriptome as defined by the Ensembl gene models version 83, with default 
parameters and the remaining unmapped genes to the Ensembl Rnor_6.0 reference rat genome from Illumina 
iGenomes web site. Trimming rates and insert length were controlled on each read group based on metrics 
reported by Trimmomatic, and Picard v1.128 respectively.
Aligned reads from multiple read groups belonging to the same sample were indexed, sorted and merged 
using sambamba v0.5.146, a faster implementation of the Samtools algorithms. Amplification duplicates were 
removed using Picard v1.128.
Various quality controls from the RNA-SeQC package were used47, including the genes detected, mapping 
rates, duplication rates, and intronic rate, based on metrics collected for each sample used.
Read count quantification, normalization and differential gene expression. Read counts were 
quantified using the summarizeOverlaps function from the GenomicAlignments R package48. Transcripts with 
a read count of 0 in both samples were removed. EdgeR49 was used to perform TMM normalization and only 
transcripts with counts per million (cpm) > 1 were used for differential analysis of genes. The NOISeq package23 
was used to screen differentially expressed genes between VMP and SU tissues. Genes with a q-value of >= 0.9 
were considered differentially expressed.
Gene Ontology enrichment analysis. Gene Ontology (GO) enrichment analysis was conducted using 
the clusterProfiler R package50 on the VMP and SU enriched genes. Ontology terms with an FDR < 0.05 were 
considered significant.
Single-cell RNA-sequencing normalization, differential gene expression and subpopulation 
analysis. The Scater package51 was used for quality control and normalization. Low quality cells were filtered 
out based on library size, number of genes detected, proportion of reads mapped to mitochondrial genome and 
the ratio of reads mapped to spike-ins. Cells were removed if they met any of the following criteria: a median 
absolute deviation (MAD) value of less than 3 for library size, a MAD value of less than 3 for number of mapped 
genes, a MAD value of greater than 3 for the ratio of reads mapped to mitochondrial DNA and a MAD value of 
greater than 3 for the ratio of reads mapped to spike-in control DNA. The numbers of cells meeting these criteria 
are detailed in Supplementary Figure 4b. Genes expressed by less than 20 cells were discarded. Gene expression 
was normalized using spike-ins. Differentially expressed genes were identified using the MAST25 and scDD26 R 
packages. Prior to subpopulation identification normalized read counts were converted to TPM and analysis was 
performed using the Seurat and SC3 R packages28,29. For both packages, marker genes were identified using a 
ROC test. All markers with an AUC < 0.75 and power < 0.4 were removed.
RNA extraction and quantitative real-time PCR. Total RNA was extracted from pooled tissues using 
Qiazol followed by the RNeasyTM Mini kit (Qiagen, Venlo, Netherlands) following manufacturer’s instructions. 
Complementary DNA synthesis was performed using the High Capacity cDNA Reverse Transcription kit 
(Applied Biosystems- ThermoFisher Scientific, Massachusetts, USA) and qPCR was performed on an ABI 7500 
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Fast machine using SYBR Select Mastermix (ThermoFisher Scientific, Massachusetts, USA). Transcript abun-
dance was normalized to four housekeeping genes; Gapdh, Tbp, Gusb and Mt-atp6. Primers used are provided 
in Table 1.
Immunohistochemistry. Immunostaining of Ebf3 and Meis2 on serial sections of female and male rat P0 
urogenital sinus tissue (isolated as per20) was performed as per24 using Ebf3 IgG (Clone 8D6, mouse monoclonal, 
Novus Biologicals, Littleton, Colorado, USA; dilution 1:1000) and Meis2 IgG (Clone 63-T, mouse monoclonal, 
Santa Cruz Biotechnology, Santa Cruz, USA; dilution 1:750). Primary antibody was omitted to serve as a negative 
control. Images were taken with an Aperio Slide Scanner (Leica, Wetzlar, Germany).
Data Availability. All data generated by this work are available in GSE103011. Differentially expressed tran-
scripts, Gene Ontology and transcript comparisons are provided in a supplementary data file.
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